Earn up to 2.25 CE/MOC Credits!
Course Description: This program will focus on key lessons learned during the COVID-19 pandemic, including how mRNA vaccine technology may be leveraged in cardiovascular medicine, what we know about thromboinflammation in COVID-19, the potential effects of long COVID syndrome on our patients and the healthcare system, and how clinicians can begin to address both the consequences of delayed cardiac care and the myriad healthcare inequities that have been uncovered over the last 18 months. The program will conclude with an interactive panel discussion and Q&A session.
- Recall how mRNA technology used to develop vaccines for COVID-19 can be leveraged in cardiovascular medicine
- Explain how the link between inflammation and thrombosis that has characterized COVID-19 has implications for other aspects of medicine
- Describe long COVID syndrome and how medicine will handle this complication of COVID-19
- Summarize trends in cardiovascular care utilization during the COVID-19 pandemic and implications for future burden of disease
- Recognize healthcare disparities exposed by COVID-19 and how medicine needs to make changes for the health of all our communities
Target Audience: Physicians, nurse practitioners, physician assistants, pharmacists, and other clinicians specializing in:
- Family Medicine
- Hospital Medicine
- Infectious Disease
- Internal Medicine
- Pulmonology & Critical Care
- Vascular Medicine
Cost: There is no cost to register for this program!
Welcome & Introductions
Gregory Piazza, MD, MS
President’s Perspective & Welcome
Samuel Z. Goldhaber, MD
Riding the Wave of mRNA Vaccine Technology: Applications in Cardiovascular Medicine
Kathryn E. Stephenson, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Staff Physician, Division of Infectious Diseases, Beth Israel Deaconess Medical Center
Thromboinflammation in COVID-19: Lessons in Thrombosis for a Post-Pandemic World
Peter Libby, MD
Mallinckrodt Professor of Medicine, Harvard Medical School
Cardiovascular Specialist, Brigham and Women’s Hospital
Long COVID Syndrome: A Pandemic After the Pandemic?
Kristin Englund, MD, MLS
Assistant Professor, Cleveland Clinic Lerner College of Medicine of CWRU
Staff Physician, Cleveland Clinic
Missed and Delayed Cardiovascular Care during the COVID-19 Pandemic: Consequences for Population Health
Karen Joynt Maddox, MD, MPH
Associate Professor, Washington University School of Medicine
Cardiologist, Barnes-Jewish Hospital
Healthcare Disparities Exposed: How COVID-19 Showed Us That We Need to Do Better
Cassandra Pierre, MD, MSc
Assistant Professor of Medicine, Boston University School of Medicine
Associate Hospital Epidemiologist, Boston Medical Center
Live Q&A and Panel Discussion
Moderated by Gregory Piazza, MD, MS
Continuing Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians. ScientiaCME designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners (NPs)
The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Nurses may claim credit for activities approved for AMA PRA Category 1 Credit(s)™ in most states for up to 50% of the nursing requirement for recertification.
Medical Practice Executives
The American College of Medical Practice Executives accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.25 hours (0.225 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-9999-21-046-L01-P. This activity is a Knowledge (K)-type activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To complete the post-assessment, please visit https://www.scientiacme.org/online-cme-courses.php?ct=10 and click on the link for “NATF 2021 Virtual Summit Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year.” This online evaluation and CE credit will not be accessible after 12/16/2021. Successful completion of the post-test with a score of 70% and completion of the program evaluation is required to obtain a CE certificate.